Conference ”Development of Cannabis-based Herbal Medicinal Products in Europe”
12th and 13th March 2025 in Berlin
Conference ”Development of Cannabis-based Herbal Medicinal Products in Europe”

For authorities, industry and science | in English

The Programme for the Cannabis Conference 2025

The development and marketing authorisation of cannabis-based medicinal products is associated with a whole range of challenges. However, they also offer opportunities for the future, since marketing them as magistral formulations based on patient-specific individual prescriptions as off-label use can only be of a temporary nature. In the future, authorised medicinal products will certainly be prescribed not only for the authorised indication but also for no-label use. Our programme will show you the way forward.

Get to know the success factors in development projects with herbal active ingredients, expand your knowledge of risks and how to counter them, and last but not least, use the event for networking and professional exchange.

 

Please note: The presentations at this conference will be held in English.

 

Programme Day 1Programme Day 2

The programme on Day 1 - Wednesday, March 12, 2025

09:00
Come Together & Registration
9:45 – 10:00
Introduction
Dr. Markus Veit (Alphatopics GmbH)
10:00 – 11:00
Cannabis as authorised medicinal product – pathways for obtaining marketing authorisations in Europe
Dr. Jacqueline Wiesner (BfArM (invited, internal approval in progess))
12:30 – 13:30
LUNCH
13:30 – 14:15
15:30 – 16:15
Navigating the future of clinical development
Ana Serrato (Avextra Pharma GmbH)

The Programme on Day 2 - Thursday, March 13, 2025

9:00 - 10:00
10:00 – 10:45
Formulation development for oral dosage forms of cannabis-based medicinal products
Dr. Norbert Pöllinger (Glatt Pharmaceutical Services GmbH & Co. KG)
10:45 – 11:15
COFFEE BREAK
12:00 – 13:00
Regulatory pathway for drug-device combination products (DDCPs)
Dr. Armin Prasch (Trias Pharma GmbH) & Dr. Markus Veit (Alphatopics GmbH)
13:00 – 14:00
LUNCH
14:00 – 14:45
Cannabis extracts – what is state of the art?
Michael Sassano (Somaí Pharmaceuticals)
14:45 – 15:30
Regulatory data protection and possibilities and limitations of IP protection in development projects
Dr. Xenia Boergen (European Patent Attorney, Boergen Rechtsanwaltskanzlei)